Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 2Other hematologic neoplasm 1Other 1Lymphoid 1Gynecologic 1

Conditions

Dysgeusia 2Radiation Injuries 1Mouth Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 631Radiotherapy 339pembrolizumab 329Cetuximab 284Docetaxel 226Radiotherapy, Intensity-Modulated 221Fluorouracil 199Carboplatin 198Paclitaxel 161Nivolumab 145Gemcitabine 125Magnetic Resonance Spectroscopy 99Radiation 91Drug Therapy 86Capecitabine 77toripalimab 75Surveys and Questionnaires 73Surgical Procedures, Operative 72Biopsy 62durvalumab 61Chemoradiotherapy 52Blood Specimen Collection 52Cyclophosphamide 50Specimen Handling 47camrelizumab 46Radiosurgery 46Erlotinib Hydrochloride 46Standard of Care 44130-nm albumin-bound paclitaxel 44tislelizumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Zinc Sulfate × Head & Neck × Clear all
NCT03824925 2019-01-31

Efficacy of Zinc on Concurrent Chemo-radiotherapy Induced Taste Alterations

Dow University of Health Sciences

Phase 3 Completed
70 enrolled
Head & Neck

Dysgeusia, Mouth Neoplasms

NCT00036881 2016-07-14

Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
173 enrolled
Head & Neck

Dysgeusia, Head and Neck Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡